Orzeyful (oveporexton)

Orzeyful (oveporexton) is filed as orexin receptor 2 agonist. The sections below restate public label fields stored for this profile.

Class
orexin receptor 2 agonist
Generic name
oveporexton
Generic available
No

Approved uses

To treat narcolepsy type 1

Common questions

What is Orzeyful approved to treat?

According to its FDA label, Orzeyful (oveporexton) is approved for: To treat narcolepsy type 1 For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Orzeyful?

Orzeyful (oveporexton) belongs to the orexin receptor 2 agonist class of medications.

Is there a generic version of Orzeyful?

Not yet. As of the most recent FDA data we ingest, no A-rated generic equivalent is listed for Orzeyful. Availability changes as patents expire.

Does Orzeyful have a Boxed Warning?

Our ingest of the FDA label for Orzeyful (oveporexton) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

Is Orzeyful currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Orzeyful (oveporexton) in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was Orzeyful approved by the FDA?

The FDA record lists the approval date for Orzeyful (oveporexton) as 2026-08-05.

Loading full data from Know Your Drugs Institute…